Table 1.
Demographic and baseline data for all randomized subjects
| Characteristic | Emixustat (N = 12) | Placebo (N = 12) | All subjects (N = 24) |
|---|---|---|---|
| Age | |||
| Mean (SD) | 52.1 (7.1) | 47.4 (11.3) | 49.8 (9.5) |
| Median | 53.0 | 49.5 | 51.5 |
| Min, max | 37, 60 | 28, 60 | 28, 60 |
| Sex, n (%) | |||
| Male | 5 (41.7) | 7 (58.3) | 12 (50.0) |
| Female | 7 (58.3) | 5 (41.7) | 12 (50.0) |
| Ethnicity, n (%) | |||
| Hispanic | 10 (83.3) | 6 (50.0) | 16 (66.7) |
| Non-Hispanic | 2 (16.7) | 6 (50.0) | 8 (33.3) |
| Race, n (%) | |||
| White | 11 (91.7) | 10 (83.3) | 21 (87.5) |
| Black or African American | 1 (8.3) | 2 (16.7) | 3 (12.5) |
| Hemoglobin A1c (%) | |||
| Mean (SD) | 8.98 (1.64) | 8.98 (1.76) | 8.98 (1.66) |
| Median | 9.25 | 9.85 | 9.50 |
| Min, max | 6.0, 11.1 | 5.8, 11.0 | 5.8, 11.1 |